NDC 80425-0227-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0227
- Requested NDC
- 80425-0227-01
- Package NDCs from labels
- 80425-0227-1, 80425-0227-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0227-1 | Ondansetron | 10 in 1 BOTTLE, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 10 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0227 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 3 | Current NDC, Legacy NDC, 1 package rows | 20250102_f1a0cd50-aa4f-55bc-e053-2995a90a2d3a.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0227-1 | EA - Each | 80425-0227 | 6b0b97f9-0549-4145-81d9-0939a1e667a5 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Northwind Health Company, LLC | f29f8ae1-4826-d8eb-e053-2a95a90a691a | 2026-01-01 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| Ondansetron | ONDANSETRON | Northwind Health Company, LLC | f2b502e2-03ed-fe5c-e053-2995a90a368e | 2026-01-01 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | Northwind Health Company, LLC | db9a0d22-9339-4319-e053-2a95a90a9592 | 2026-01-01 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Northwind Health Company, LLC | 852a3251-bf28-5557-e053-2991aa0a4fbd | 2026-01-01 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Northwind Health Company, LLC | db99c77a-0b01-9da6-e053-2a95a90a5199 | 2026-01-01 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| Ondansetron | ONDANSETRON | Northwind Health Company, LLC | e07c38c0-e1c2-01de-e053-2995a90a390a | 2026-01-01 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | Northwind Health Company, LLC | f29f5cfa-3cc4-7d53-e053-2995a90ae844 | 2025-12-26 | Warnings, Adverse reactions | ANDA078152 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | Redpharm Drug | 300b1916-a3d8-0220-e063-6394a90a6f55 | 2025-12-23 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| Ondansetron | ONDANSETRON | Ipca Laboratories Limited | 8e24f935-87fe-4b6a-b265-60b1039f38d5 | 2025-12-22 | Warnings, Adverse reactions | 312087 104894 4AF302ESOS |
| Ondansetron | ONDANSETRON | Natco Pharma USA LLC | 64527de5-0b92-4340-9243-7a37e8ff96d9 | 2025-12-19 | Warnings, Adverse reactions | 312086 198052 NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | QPharma, Inc. | fbe71308-2927-2467-e053-6394a90aa419 | 2025-12-16 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | QPharma, Inc. | 2fa30bdb-f60e-40a7-98b4-c346bc85d539 | 2025-12-15 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | QPharma, Inc. | dafe875e-391f-47a2-97b7-89840a760e44 | 2025-12-15 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| Ondansetron | ONDANSETRON | Hospira, Inc. | e0862c02-781f-4b10-ae50-9c9c4ca26f6d | 2025-12-01 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | AvKARE | 352de988-d166-c2d8-e063-6294a90acc01 | 2025-11-17 | Warnings, Adverse reactions | ANDA078152 312087 104894 4AF302ESOS |
| ondansetron hydrochloride | ONDANSETRON HYDROCHLORIDE | Onesource Specialty Pharma Limited | 438c3d28-8bed-50f0-e063-6394a90a18e4 | 2025-11-14 | Warnings, Adverse reactions | NMH84OZK2B |
| ondansetron hydrochloride | ONDANSETRON HYDROCHLORIDE | Onesource Specialty Pharma Limited | a5fe05bc-a7a5-4131-8c4d-2edd113441ec | 2025-11-14 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | Bryant Ranch Prepack | 7949c245-b79f-4eaf-a75f-9a17bd7bd307 | 2025-11-06 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| Ondansetron | ONDANSETRON | Proficient Rx LP | 81366c85-c6c9-4a9a-9fe5-cdd8c2d19f74 | 2025-11-01 | Warnings, Adverse reactions | ANDA078152 312087 104894 4AF302ESOS |
| ondansetron | ONDANSETRON | Accord Healthcare, Inc. | 35e0d160-813f-41d7-a382-d2cab6485d9c | 2025-10-29 | Warnings, Adverse reactions | 4AF302ESOS |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.